Show simple item record

dc.contributor.authorDowling, Jennifer K
dc.contributor.authorTate, Michelle D
dc.contributor.authorRosli, Sarah
dc.contributor.authorBourke, Nollaig M
dc.contributor.authorBitto, Natalie
dc.contributor.authorLauterbach, Mario A
dc.contributor.authorCheung, Shane
dc.contributor.authorVe, Thomas
dc.contributor.authorKobe, Bostjan
dc.contributor.authorGolenbock, Douglas
dc.contributor.authorMansell, Ashley
dc.date.accessioned2019-07-31T04:48:29Z
dc.date.available2019-07-31T04:48:29Z
dc.date.issued2019
dc.identifier.issn0022-1767
dc.identifier.doi10.4049/jimmunol.1800501
dc.identifier.urihttp://hdl.handle.net/10072/384601
dc.description.abstractMyD88 adaptor-like (Mal) protein is the most polymorphic of the four key adaptor proteins involved in TLR signaling. TLRs play a critical role in the recognition and immune response to pathogens through activation of the prototypic inflammatory transcription factor NF-κB. The study of single nucleotide polymorphisms in TLRs, adaptors, and signaling mediators has provided key insights into the function of the corresponding genes but also into the susceptibility to infectious diseases in humans. In this study, we have analyzed the immune response of mice carrying the human Mal-D96N genetic variation that has previously been proposed to confer protection against septic shock. We have found that Mal-D96N macrophages display reduced cytokine expression in response to TLR4 and TLR2 ligand challenge. Mal-D96N macrophages also display reduced MAPK activation, NF-κB transactivation, and delayed NF-κB nuclear translocation, presumably via delayed kinetics of Mal interaction with MyD88 following LPS stimulation. Importantly, Mal-D96N genetic variation confers a physiological protective phenotype to in vivo models of LPS-, Escherichia coli-, and influenza A virus-induced hyperinflammatory disease in a gene dosage-dependent manner. Together, these results highlight the critical role Mal plays in regulating optimal TLR-induced inflammatory signaling pathways and suggest the potential therapeutic advantages of targeting the Mal D96 signaling nexus.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofpagefrom2384
dc.relation.ispartofpageto2396
dc.relation.ispartofissue8
dc.relation.ispartofjournalJournal of Immunology
dc.relation.ispartofvolume202
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode3204
dc.titleThe single nucleotide polymorphism MAL-D96N mice provide new insights into functionality of Mal in TLR immune responses
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.hasfulltextNo Full Text
gro.griffith.authorVe, Thomas
gro.griffith.authorKobe, Bostjan


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record